Nitric Oxide-Releasing Acetylsalicyclic Acid in Preventing Colorectal Cancer in Patients at High Risk of Colorectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing,
or coming back. The use of nitric oxide-releasing acetylsalicyclic acid may prevent
colorectal cancer.
PURPOSE: This randomized phase I trial is studying the side effects and best dose of nitric
oxide-releasing acetylsalicyclic acid in preventing colorectal cancer in patients at high
risk of colorectal cancer.